
欧洲医用酶技术市场预测至 2028 年 - COVID-19 影响和酶类型(消化酶、溶栓酶、水解酶和核酸内切酶)的区域分析;应用(疾病治疗、诊断工具、生物医学研究等)
No. of Pages: 173 | Report Code: TIPRE00025045 | Category: Life Sciences
No. of Pages: 173 | Report Code: TIPRE00025045 | Category: Life Sciences
酶是植物、动物和微生物的活细胞中产生的蛋白质。所有生物体都需要酶来生长以及产生和利用生命所必需的能量。在活细胞中,酶充当催化剂,加速控制生命过程的化学反应。一百多年来,酶一直是重要的工业产品。然而,潜在的应用范围正在迅速扩大。随着重组 DNA 技术的出现,大量生产以前稀有的酶已成为可能,从而降低了成本。此外,在药品制造中,制造手性纯化合物的愿望正在带来新的机遇。技术进步促进了酶在越来越广泛的工艺条件下的使用。
因此,研究和开发活动的显着增加预计将在未来几年对医用酶技术产生巨大需求,预计这将进一步推动医用酶技术市场的发展。
欧洲地区国家因 COVID-19 大流行而受到严重影响。例如,意大利、西班牙和法国等国家报告的阳性病例数最多,死亡人数最多。欧洲国家在今年年初成功缓解疫情后,发现 COVID-19 病例再次出现。许多国家现在每天宣布的病例数量比今年早些时候第一波疫情期间还要多。根据欧洲疾病预防和控制中心 (ECDC) 的数据,英国、西班牙、意大利和爱尔兰正在重新实施封锁。与此同时,欧洲正试图从 COVID-19 危机对公民健康和经济稳定的影响中恢复过来。欧洲绿色协议中的新政策将试图减轻疫情的影响。生物技术可以成为这一复苏的宝贵工具,从帮助我们实现“从农场到餐桌”战略目标的现代植物育种方法,到帮助我们阻止大流行的制药和医疗创新。农业生物技术改善了动物营养,开发了动物疫苗,并改进了疯牛病、口蹄疫和沙门氏菌的诊断。它还使得酶的使用成为可能。因此,欧洲基因组市场在这次大流行期间和预测的年份可能会显示出显着的增长前景。
欧洲医用酶技术市场预计将从2021年的11.645亿美元增长到2028年的17.996亿美元;预计 2021 年至 2028 年复合年增长率为 6.4%。生物制药是制药和生物技术行业不断增长的业务领域之一。自 1982 年推出以来,生物制药彻底改变了多种疾病的治疗方法,并且越来越多地应用于几乎所有医学分支。尽管需要投入大量时间和资金,生物制药市场仍在快速增长。
从酶类型来看,水解酶领域占据2020年欧洲医用酶技术市场最大份额。从应用来看,疾病治疗领域占据欧洲医用酶最大份额2020 年技术市场。
准备本欧洲医用酶技术市场报告时参考的一些主要一手和二手资料包括公司网站、年度报告、财务报告、国家政府文件和统计数据库,除其他外。报告中列出的主要公司包括 Merck Kgaa、Thermo Fisher Scientific Inc.、Novozymes、Takeda Pharmaceutical Company Limited、Agilent Technologies, Inc.、Genzyme Corporation、Asahi Kasei Corporation、Promega Corporation、Cytiva 和 Amano Enzyme Inc.
< strong>欧洲医疗酶技术市场细分
按酶类型
按应用
< /p>
按国家/地区
Strategic insights for Europe Medical Enzyme Technology involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 1,164.5 Million |
Market Size by 2028 | US$ 1,799.6 Million |
Global CAGR (2021 - 2028) | 6.4% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By 酶类型
|
Regions and Countries Covered | 欧洲
|
Market leaders and key company profiles |
The regional scope of Europe Medical Enzyme Technology refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Europe Medical Enzyme Technology Market is valued at US$ 1,164.5 Million in 2021, it is projected to reach US$ 1,799.6 Million by 2028.
As per our report Europe Medical Enzyme Technology Market, the market size is valued at US$ 1,164.5 Million in 2021, projecting it to reach US$ 1,799.6 Million by 2028. This translates to a CAGR of approximately 6.4% during the forecast period.
The Europe Medical Enzyme Technology Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Medical Enzyme Technology Market report:
The Europe Medical Enzyme Technology Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Medical Enzyme Technology Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Medical Enzyme Technology Market value chain can benefit from the information contained in a comprehensive market report.